PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummaryJul 15, 2002	Recently Approved Spinal Fusion Device and Bone Graft Using Genetically Engineered Protein Utilizes Integra LifeSciences' Absorbable Collagen Sponge Recently Approved Spinal Fusion Device and Bone Graft Using Genetically Engineered Protein Utilizes Integra LifeSciences' Absorbable Collagen Sponge Plainsboro, New Jersey, July 15, 2002-- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that its Absorbable Collagen Sponge	View HTML Recently Approved Spinal Fusion Device and Bone Graft Using Genetically Engineered Protein Utilizes Integra LifeSciences' Absorbable Collagen Sponge 12.4 KB
Toggle SummaryMay 8, 2002	Integra LifeSciences Reports First Quarter Earnings Per Share of $0.13 on Record Revenues of $25.9 Million Integra LifeSciences Reports First Quarter Earnings Per Share of $0.13 on Record Revenues of $25.9 Million PLAINSBORO, N.J., May 8, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today reported record revenues of $25.9 million and net income of $0.13 per share for the	View HTML Integra LifeSciences Reports First Quarter Earnings Per Share of $0.13 on Record Revenues of $25.9 Million 18.2 KB
Toggle SummaryApr 23, 2002	Integra LifeSciences Announces FDA Approval to Market INTEGRA Dermal Regeneration Template for the Repair of Scar Contractures Integra LifeSciences Announces FDA Approval to Market INTEGRA Dermal Regeneration Template for the Repair of Scar Contractures PLAINSBORO, N.J., April 23, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that the U.S.	View HTML Integra LifeSciences Announces FDA Approval to Market INTEGRA Dermal Regeneration Template for the Repair of Scar Contractures 13.1 KB
Toggle SummaryApr 9, 2002	Integra NeuroSciences Announces FDA Clearance to Market a Tunneled Catheter for the LICOX Brain Tissue Oxygen Monitoring System; Product Launch to Begin in Second Quarter Integra NeuroSciences Announces FDA Clearance to Market a Tunneled Catheter for the LICOX Brain Tissue Oxygen Monitoring System; Product Launch to Begin in Second Quarter PLAINSBORO, N.J., April 9, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that	View HTML Integra NeuroSciences Announces FDA Clearance to Market a Tunneled Catheter for the LICOX Brain Tissue Oxygen Monitoring System; Product Launch to Begin in Second Quarter 10.5 KB
Toggle SummaryApr 5, 2002	Integra LifeSciences Reports Preliminary First Quarter 2002 Revenues; Forward-Looking Earnings Guidance Unchanged Integra LifeSciences Reports Preliminary First Quarter 2002 Revenues; Forward-Looking Earnings Guidance Unchanged PLAINSBORO, N.J., April 5, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today reported preliminary revenues for the first quarter ended March 31, 2002.	View HTML Integra LifeSciences Reports Preliminary First Quarter 2002 Revenues; Forward-Looking Earnings Guidance Unchanged 13.3 KB
Toggle SummaryMar 8, 2002	Integra LifeSciences Announces Investor Forum at the American Association of Neurological Surgeons Meeting on April 9, 2002 Integra LifeSciences Announces Investor Forum at the American Association of Neurological Surgeons Meeting on April 9, 2002 PLAINSBORO, N.J., March 8, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) announced today that it has scheduled an Investor Forum at the American	View HTML Integra LifeSciences Announces Investor Forum at the American Association of Neurological Surgeons Meeting on April 9, 2002 11.3 KB
Toggle SummaryFeb 27, 2002	Integra LifeSciences Reports Record Fourth Quarter and Full Year 2001 Earnings on a 'Fully Taxed' Basis Integra LifeSciences Reports Record Fourth Quarter and Full Year 2001 Earnings on a 'Fully Taxed' Basis Operating Earnings Before Interest, Taxes, Depreciation and Amortization Totaled $6.1 Million for the Fourth Quarter of 2001 and $20.2 Million for the Full Year 2001 PLAINSBORO, N.J., Feb.	View HTML Integra LifeSciences Reports Record Fourth Quarter and Full Year 2001 Earnings on a 'Fully Taxed' Basis 28.4 KB
Toggle SummaryFeb 20, 2002	Integra LifeSciences Schedules Conference Call for Wednesday, February 27 to Discuss Fourth Quarter and Full Year 2001 Financial Results and Update Forward-Looking Financial Guidance Integra LifeSciences Schedules Conference Call for Wednesday, February 27 to Discuss Fourth Quarter and Full Year 2001 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J. Feb. 20, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) announced	View HTML Integra LifeSciences Schedules Conference Call for Wednesday, February 27 to Discuss Fourth Quarter and Full Year 2001 Financial Results and Update Forward-Looking Financial Guidance 10.5 KB
Toggle SummaryJan 29, 2002	Integra LifeSciences Reports Preliminary Fourth Quarter 2001 Revenues -- Product Sales Increase 26%; Full Financial Results to be Reported on February 27, 2002 Integra LifeSciences Reports Preliminary Fourth Quarter 2001 Revenues -- Product Sales Increase 26@Full Financial Results to be Reported on February 27, 2002 PLAINSBORO, N.J., Jan. 29, 2002 (PRIMEZONE) -- Led by strong growth in product sales, Integra LifeSciences Holdings Corporation (Nasdaq:	View HTML Integra LifeSciences Reports Preliminary Fourth Quarter 2001 Revenues -- Product Sales Increase 26%; Full Financial Results to be Reported on February 27, 2002 15.7 KB
Toggle SummaryJan 22, 2002	Integra LifeSciences to Present at the US Bancorp Piper Jaffray Health Care Conference Integra LifeSciences to Present at the US Bancorp Piper Jaffray Health Care Conference PLAINSBORO, N.J., Jan 22, 2002 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it is scheduled to present at the US Bancorp Piper Jaffray Health Care Conference at	View HTML Integra LifeSciences to Present at the US Bancorp Piper Jaffray Health Care Conference 10.1 KB
Toggle SummaryJan 14, 2002	Integra NeuroSciences Direct Salesforce Begins Marketing Helitene Hemostatic Agent Integra NeuroSciences Direct Salesforce Begins Marketing Helitene Hemostatic Agent PLAINSBORO, N.J., Jan 14, 2002 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that its Integra NeuroSciences division has begun marketing Helitene® Absorbable	View HTML Integra NeuroSciences Direct Salesforce Begins Marketing Helitene Hemostatic Agent 12 KB
Toggle SummaryJan 11, 2002	FDA Panel Recommends rhBMP-2 Product Including Integra LifeSciences Absorbable Collagen Sponge FDA Panel Recommends rhBMP-2 Product Including Integra LifeSciences Absorbable Collagen Sponge PLAINSBORO, N.J.--(BUSINESS WIRE)--Jan. 11, 2002--Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the Orthopedic and Rehabilitation Devices Panel of the United States Food and	View HTML FDA Panel Recommends rhBMP-2 Product Including Integra LifeSciences Absorbable Collagen Sponge 12.3 KB
Toggle SummaryDec 7, 2001	Integra LifeSciences Announces Acquisition of NeuroSupplies, Inc., a Specialty Distributor of Neurology Supplies Integra LifeSciences Announces Acquisition of NeuroSupplies, Inc., a Specialty Distributor of Neurology Supplies PLAINSBORO, N.J., Dec 7, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) announced today that it has acquired NeuroSupplies, Inc., a specialty	View HTML Integra LifeSciences Announces Acquisition of NeuroSupplies, Inc., a Specialty Distributor of Neurology Supplies 14.1 KB
Toggle SummaryNov 7, 2001	Integra LifeSciences Reports Record Third Quarter Net Income on 31% Growth in Product Sales Integra LifeSciences Reports Record Third Quarter Net Income on 31 PLAINSBORO, N.J., Nov 7, 2001 (BUSINESS WIRE) -- Operating Earnings Before Interest, Taxes, Depreciation and Amortization Totaled $5.4 Million Led by strong growth in product sales, Integra LifeSciences Holdings Corporation (Nasdaq:	View HTML Integra LifeSciences Reports Record Third Quarter Net Income on 31% Growth in Product Sales 22.3 KB
Toggle SummaryOct 31, 2001	Integra LifeSciences Schedules Conference Call for Wednesday, November 7 to Discuss Third Quarter 2001 Financial Results and Provide Forward-Looking Earnings Guidance Integra LifeSciences Schedules Conference Call for Wednesday, November 7 to Discuss Third Quarter 2001 Financial Results and Provide Forward-Looking Earnings Guidance PLAINSBORO, N.J., Oct 31, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced that it has	View HTML Integra LifeSciences Schedules Conference Call for Wednesday, November 7 to Discuss Third Quarter 2001 Financial Results and Provide Forward-Looking Earnings Guidance 10.4 KB